The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Sunitinib in patients with metastatic non-clear renal cell carcinoma: A multicentric retpospective Turkish Oncology Group (TOG) trial.
Ibrahim Yildiz
No relevant relationships to disclose
Meltem Ekenel
No relevant relationships to disclose
Tulay Akman
No relevant relationships to disclose
Muharrem Kocar
No relevant relationships to disclose
Mukremin Uysal
No relevant relationships to disclose
Metin Kanitez
No relevant relationships to disclose
Vedat Bayoglu
No relevant relationships to disclose
Umut Varol
No relevant relationships to disclose
Deniz Tural
No relevant relationships to disclose
Nilufer Avci
No relevant relationships to disclose
Muhammet Ali Kaplan
No relevant relationships to disclose
Zeki Surmeli
No relevant relationships to disclose
Isa Dede
No relevant relationships to disclose
Arife Ulas
No relevant relationships to disclose
Ozan Yazici
No relevant relationships to disclose
Mert Basaran
No relevant relationships to disclose